NVO financials
Novo Nordisk (NVO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
NVO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $309.06B | $250.28B | $127.66B | $102.43B | 23.03 |
| 2024 | $290.40B | $245.88B | $128.34B | $100.99B | 22.63 |
| 2023 | $232.26B | $196.50B | $102.57B | $83.68B | 18.62 |
| 2022 | $176.95B | $148.51B | $74.81B | $55.52B | 12.22 |
| 2021 | $140.80B | $117.14B | $58.64B | $47.76B | 10.37 |
| 2020 | $126.95B | $106.01B | $54.13B | $42.14B | 9.01 |
- NVO revenue was $309.06B in fiscal 2025, net income $102.43B.
Updated 2026-11-02 19:55 UTC